For example, Ginsenoside Rb1 was reported to ameliorate motor deficits in a mouse model of Parkinson’s disease, potentially by reducing glutamate-mediated neurotoxicity by upregulated expression of the GLT-1 glutamate transporter (34). The gene discussed is SLC1A2; the disease is Parkinson disease.